Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH, March 19, 2026--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage ...
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE)-- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by ...
In a landmark development, Neuracle Medical Technology has secured the country’s first-ever approval for an implantable brain-computer interface (BCI) system designed to restore hand motor function in ...
Writing is one of the most powerful learning tools we have. It enables what we value most in research and learning: exploration, discovery, expression, conversation, and consensus building. Skills ...
Java is becoming more popular for building AI applications, with 62% of respondents in Azul’s just-released 2026 State of Java Survey and Report relying on Java for AI development. Last year’s report ...
CARROLLTON, GA, UNITED STATES, January 30, 2026 /EINPresswire.com/ — CareTrack, a leading provider of remote healthcare solutions, is excited to announce positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results